Spanish adaptation of the European guidelines for the evaluation and treatment of actinic keratosis
Ferrándiz C(1), Fonseca-Capdevila E(2), García-Diez A(3), Guillén-Barona C(4), Belinchón-Romero I(5), Redondo-Bellón P(6), Moreno-Giménez JC(7), Senán R(8).
Current trends in our setting indicate that the prevalence of actinic keratosis and similar diseases will increase in coming years and impose a greater burden on health care resources. A long list of clinical features must be taken into account when approaching the treatment of actinic keratosis.
Until recently, therapeutic approaches focused solely on ablative procedures and the treatment of individual lesions and did not take into account areas of field cancerization. Now that the therapeutic arsenal has grown, standardized criteria are needed to guide the optimal choice of treatment for each patient.
The elaboration of evidence-based consensus recommendations for the diagnosis and treatment of actinic keratosis generates knowledge that will help clinicians to deliver the highest level of care possible, standardizing decision-making processes and enhancing awareness among all the health professionals involved in the care pathway.
CITATION Actas Dermosifiliogr. 2014 May;105(4):378-93. doi: 10.1016/j.adengl.2013.11.004.